This guideline includes statements and recommendations based on available, high-level evidence about the use of hypofractionated radiotherapy for the treatment of women with early (operable) breast cancer. The guideline aims to provide health professionals with information designed to assist in making management recommendations for patient outcomes. These guidelines will inform the development of information specifically for consumers about early breast cancer, including treatment options.
A clinical practice guideline developed by Cancer Australia*
This guideline supplements guideline recommendations 10 on the use of radiotherapy (page 8) and information about radiotherapy (pages 67-75) in the Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001.
Incorporates published evidence to July 2011
Endorsed by:
- The Faculty of Radiation Oncology - The Royal Australian and New Zealand College of Radiologists
Document identification:
ISBN Online: 13 978-1-74127-175-1
© Cancer Australia 2011
* In July 2011, National Breast and Ovarian Cancer Centre (NBOCC) amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.
| Guideline Topic | Early breast cancer |
| Cancer Types | Breast cancer |
This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.